Researcher Image
محمد باسل إسماعيل - Mohammed Bassil Ismail
PhD - assistant professor
College of Medicine , Surgery
[email protected]
Summary

assistant professor Mohammed Bassil Ismail ; head of urology department and assistant dean for scietific affairs and postgradute studies ,college of medicine, university of Baghdad. consultant urologist, subspeciality functional surgery ,Head of functional urology and neuromodulation ,Surgical Specialties Hospital, medical city complex.

Qualifications

2004 College of medicine Nahrin M.B.Ch.B 2013 Council of urology Arabic council for medical specialization Ph.D. (Board) 2020 Council of functional surgery Arabic council for medical specialization subspecialty

Responsibility

2024-now assistant dean for scietific affairs and postgradute studies ,college of medicine, university of Baghdad. 2023-now Medical city, surgical specialties hospital Consultant urologist 2020-now Medical city, surgical specialties hospital Subspecialty of functional urology 2020-now College of medicine, Baghdad university Assistant professor of urology 2019-now Arabic council of medical specialization Director of functional surgery council 2020-now College of medicine, Baghdad university Director of surgery department 2017-now College of medicine, Baghdad university Chief of urology department 2012-now Medical city, surgical specialties hospital Senior of urology 2012-2020 College of medicine, Baghdad university Lecturer of urology 2009-2012 Medical city, surgical specialties ,hospital, urology department Chief of residents

Research Interests

Urinary IncontinenceUrogynecology & Female UrologyUrologic OncologyUrodynamicsNerve StimulationNeurogenic Urinary BladderNeurourologyIncontinenceSuburethral SlingsUrinary RetentionVesicovaginal FistulaUrge Urinary IncontinenceOveractive Urinary BladderStress Urinary IncontinencePediatric UrologyEndourologyUrolithiasisEnuresisProstate

Publication Date
Thu Oct 29 2020
Journal Name
Indian Journal Of Forensic Medicine & Toxicology
Testing the New Parameters affecting The Outcome of Extracorporeal Shockwave Lithotripsy for Upper Ureteric Stones
...Show More Authors

Background: Extracorporeal Shock wave lithotripsy (ESWL) is widely used in treating patients with ureteralstones because it is effective, safe, and noninvasive. Based on factors such as size and the location of stones,there is a significant variation in the overall stone-free rate (SFR).Aim of the study: To evaluate the effect of ureteral wall thickness (UWT), stone attenuation, the time fromfirst attack of pain till first session of ESWL and stone/ rib density on the outcome of SWL in the treatmentof upper ureteral stones (UUS).Patient and methods: A prospective study when 127 patients with radio-opaque UUS ranging from 7 to 20mm and treated by ESWL were included in this study. The effect of (stone/ 12th rib) density by KUB, ureter

... Show More
View Publication
Scopus (2)
Crossref (1)
Scopus Crossref
Publication Date
Wed Jan 01 2020
Journal Name
Medico-legal Update
Flexible ureterorenoscopy versus extracorporeal shock wave lithotripsy for treatment of lower pole renal stones
...Show More Authors

Scopus (1)
Scopus
Publication Date
Thu Jan 07 2021
Journal Name
Indian Journal Of Forensic Medicine & Toxicology
Efficacy and Safety of Sacral Neuromodulation in Treatment of Refractory Overactive Bladder
...Show More Authors

View Publication
Scopus (1)
Scopus Crossref
Publication Date
Fri May 15 2020
Journal Name
International Journal Of Research In Pharmaceutical Sciences
Urodynamic findings of bladder dysfunction in patients with Type 2 DM
...Show More Authors

Bladder dysfunction is one of the most common complications of diabetes, even exceeding nephropathy or peripheral neuropathy. Diabetic cystopathyaffects patients in both sexes, and its prevalence increases over time with diabetes; our concern is to evaluate the urodynamic findings of bladder dysfunction in diabetic patients.A cross sectional study conducted at Ghazi Al-Hariri Surgical specialized hospital during the period from the firsts of January 2018 to the end of Mar 2019, in which 118 diabetic patients (71 female and 47 male) with lower urinary tract symptoms were enrolled in the current study. The mean age (62±13) years old, 37.3% of patients presented with urgency as the main type of dysfunction. Diabetic cystopathy were fo

... Show More
View Publication
Scopus (1)
Scopus Crossref
Publication Date
Thu Dec 15 2022
Journal Name
Bionatura
NDRG1 is being investigated as a possible bladder cancer biomarker in the Iraqi population.
...Show More Authors

With 549,393 new cases recorded in 2018, bladder cancer is one of the most common malignancies worldwide. Urinary bladder cancer is the cause of about 3 percent of all new cancer diagnoses and 2.1 percent of all cancer deaths. This study aims to evaluate the efficiency of the N-myc downstream-regulated gene 1(NDRG1) as a biomarker for bladder cancer patients in the Iraqi population. One hundred individuals in the case-control study were enrolled and divided into two groups. The first group included 50 patients diagnosed with a bladder mass and investigated by undergoing cystoscopy examination for transurethral resection of bladder tumor (TURB). The second group included 50 healthy individuals who had normal bladder tissue. The resul

... Show More
View Publication
Scopus Crossref
Publication Date
Wed May 22 2024
Journal Name
Al-rafidain Journal Of Medical Sciences ( Issn 2789-3219 )
Assessment of Urine and Serum Exosomes as Biomarkers for the Diagnosis of Bladder Cancer
...Show More Authors

Background: Bladder cancer (BC) is the most common malignant tumor in the urinary tract and the tenth most common malignancy worldwide. Exosomes are 40–100 nm-diameter nanovesicles that are either released straight from the plasma membrane during budding or merged with the plasma membrane by multivesicular bodies. Objectives: To assess the proportion of serum and urinary Exosome levels in urinary bladder cancer patients, as well as their impact on the disease. Methods: From January 2023 to June 2023, a total of 45 samples of blood and urine were collected from individuals diagnosed with bladder cancer at the Ghazi Hariri Hospital for Specialized Surgery. They included 45 male and female patients, varying in age, as well as 45 heal

... Show More
View Publication
Scopus Crossref
Publication Date
Sun Jun 30 2024
Journal Name
Romanian Medical Journal
Serum and urine apolipoprotien A1 (ApoA1) as biomarkers in bladder cancer
...Show More Authors

Bladder cancer (BC) is the predominant malignant neoplasm in the urinary system and ranks as the tenth most prevalent malignant tumor worldwide. Compared with females, males displayed a four-fold more common incidence of bladder cancer. It mainly affects men. Bladder cancer is the fourth most prevalent neoplasm in males. The most important protein that makes up high density lipoprotein (HDL), ApoA-I apolipoprotein A1 is essential in regulating the right amount of cholesterol. Multiple inquiries have demonstrated that APOA1 plays a pivotal role in the progression, infiltration, and spread of tumors. Objectives. The objective of this study was to measure the level of urine to serum apolipoprotein A1 in patients suffering from bladder

... Show More
View Publication
Scopus Crossref
Publication Date
Mon Jan 01 2024
Journal Name
Journal Of Natural Science, Biology And Medicine
Effectiveness of Frenulum Subcutaneous Injection of Botox in the Treatment of Premature Ejaculation
...Show More Authors

Scopus
No Events Found